Keynote Speakers

Keynote I


Prof. Jun F. (James) Liang
Stevens Institute of Technology, New Jersey, USA

Recent Publications:
Traba C, Chen L, Azzam R, Liang JF, “Insights into discharge argon-mediated biofilm inactivation”. Biofouling, 29:1205-13 (2013). 
Chen L, Liang JF, “Improved stability of bioactive peptides by controlling peptide assembling”. Biomacromolecules. 14:2326-31(2013). 
Chen L, Dong S, Liang JF, “The Effects of Metal Ions on the Cytotoxicity and Selectivity of a Histidine-Containing Lytic Peptides” Int. J. Pept Res Ther. 19: 611-623, (2013).
Traba C, Chen L., Liang JF, “Low power gas discharge plasma mediated inactivation and removal of biofilms formed on biomaterials”. Cur. Appl. Phys, 13:12-18 (2013). 
Chen L., Patrone N., Liang JF, “Peptide self-assembly on cell membranes to induce cell lysis”, Biomacromolecules, 13(10):3327-33 (2012)
Chen L, Tu Z Voloshchuk N, Liang JF, “Lytic peptides with improved stability and selectivity designed for cancer treatment”. J Pharm Sci. 101(4):1508-17 (2012).
Chen L, Liang JF, “Metabolic monosaccharides altered cell responses to anticancer drugs”. Eur J Pharm Biopharm. 81(2):339-45 (2012).
Kharidia R, Tu Z., Chen L., Liang JF, “Activity and Selectivity of Histidine-Containing Lytic Peptides to Antibiotic Resistant Bacteria”. Arch Microbiol . 194 (4) 579-685 (2012).

Recently Area:
Nano-Technology Enabled Bacteria and Cancer Cell Sensing.  Recently, we are working on a nano-patterning technology which can be used in biosensor and other analytic devices in combination with specific molecules (peptides and signaling massagers) for high sensitivity molecular and cell (bacteria and tumor) sensing. Meanwhile, a novel nano-crystalization technology with targeting and controlled release properties is being studied for drugs (anticancer drugs, antibiotics) with poor solubility and limited therapeutic effectiveness.

Keynote II

Prof. Khaled M. Bali
University of California, San Diego, USA

Prof. K. M. Bali is an Irrigation/Water Management Advisor and County Director at the University of California Desert Research and Extension Center in Holtville, California. He holds a Ph.D. Degree (1992) in Soil Science (soil physics) and MS Degree (1987) in Water Science (Irrigation and Drainage) from the University of California at Davis. He holds a Bachelor of Science Degree (1984) in soils and irrigation from the University of Jordan, Amman.
His main fields of scientific interest include water resources and management, water quality, irrigation systems, automation of surface irrigation, evapotranspiration, salinity, water quality, and reuse of wastewater for irrigation.
Dr. Bali a member of many professional societies as American Geophysical Union and United States Committee on Irrigation and Drainage. He is a U.S. Fulbright Scholar and served on a number of National and International Scientific Committees.

Keynote III

Prof. Helmut Zarbl
Rutgers, The State University of New Jersey, USA

Dr. Helmut Zarbl has more than 32 years of research experience focused on understanding molecular mechanisms of toxicity, mutagenesis, carcinogenesis, toxicogenomics, as well as epigenetic and genetic mechanisms of disease susceptibility and chemoprevention. He received his Ph.D. in Biochemistry from McGill University in 1983, followed by a postdoctoral fellowship in the laboratory of Dr. Mariano Barbacid at the National Cancer Institute (NIH). He subsequently did a postdoctoral research with Dr. Paul Jolicoeur at the Clinical Research Institute of Montreal. He began his academic career at the Massachusetts Institute of Technology (MIT), in 1987, where he rose to the rank of Associate Professor and became the Deputy Director of their Environmental Health Sciences Center.  In 1994, he joined the Fred Hutchinson Cancer Research Center (FHCRC) in Seattle, WA, where he established, designed, staffed and directed the FHCRC’s Genomics facility. He also served as the Director of Core Laboratories operated by the FHCRC Division of Public Health Sciences (PHS). He founded and served as the Director of the NIEHS Sponsored University of Washington/FHCRC Toxicogenomics Research Consortium, serving as the Director of the National Steering committee for two years.

In 2007 Dr. Zarbl joined the Department of Environmental and Occupational Medicine at Robert Wood Johnson Medical School at Rutgers, where he assumed the Directorship of the NIEHS funded Center for Environmental Exposures and Disease. He also served as the Associate Director for Public Health Sciences at the Rutgers Cancer Institute of New Jersey from 2008-2013. He is currently Professor of Environmental and Occupational Health in the Rutgers School of Public Health.  He serves on national and international grant review panels, as well as scientific advisory boards to numerous university, non-profit and government agencies. He is a member of the USA National Academies, NRC Standing Committee on Emerging Science for Environmental Health Decisions.

Dr. Zarbl is also the founding President of GeneAsses, Inc., a joint university and industry partnership whose mission is to translate research on differential susceptibility to environmental carcinogenesis into new diagnostic and prognostic tests, and therapies.